Suppr超能文献

美国持续性非卧床腹膜透析患者适合增量腹膜透析吗:是或否?

Are USPD patients suitable for incremental peritoneal dialysis: Yes or no?

出版信息

Clin Nephrol. 2022 Apr;97(4):215-225. doi: 10.5414/CN110471.

Abstract

BACKGROUND

Incremental peritoneal dialysis (IPD) is the practice of initiating PD exchange less than 4 times a day in consideration of residual renal function (RRF). This study determined whether IPD could be used for urgent-start peritoneal dialysis (USPD) patients when starting dialysis, and when compared to full-dose PD, could IPD affect the RRF in USPD patients.

MATERIALS AND METHODS

169 USPD patients with eGFR between 4 and 6 mL/min/1.73m were retrospectively analyzed. The duration of follow-up was 1 year. Patients were divided into an incremental PD (i-PD) group (dialysis dose ≤ 6,000 mL) and a full-dose PD (f-PD) group (dialysis dose ≥ 8,000 mL). The demographics, clinical indices, peritoneal transport function, dialysis adequacy, and complications of peritoneal dialysis were compared between both groups.

RESULTS

(1) 111 patients (average age 45.01 ± 12.84 years) were included in the i-PD group and 58 patients (average age 43.5 ± 15.62 years) in the f-PD group. The demographics and clinical indices of both groups before PD were similar (p < 0.05). (2) During the follow-up period, the dialysis dose in the f-PD group exceeded that of the i-PD group (p < 0.05). The dialysis adequacy of both groups was as expected. (3) During the follow-up period, peritoneal transport function, the RRF, the blood pressure control, correction of anemia, and correction of calcium and phosphorus abnormalities were similar in both groups. (4) The peritoneal dialysis-related infection, mechanical complications, and technical survival rate were similar between groups.

CONCLUSION

Incremental PD did not cause a rapid decline of RRF in USPD patients. The dialysis effect and complications from it, were similar to full-dose peritoneal dialysis. Thus, USPD patients can be treated by IPD.

摘要

背景

在考虑残余肾功能(RRF)的情况下,增量腹膜透析(IPD)是指每天少于 4 次开始 PD 交换的做法。本研究旨在确定在开始透析时,IPD 是否可用于紧急起始腹膜透析(USPD)患者,与全剂量 PD 相比,IPD 是否会影响 USPD 患者的 RRF。

材料和方法

回顾性分析了 169 例 eGFR 为 4 至 6 mL/min/1.73m2 的 USPD 患者。随访时间为 1 年。患者被分为增量 PD(i-PD)组(透析剂量≤6000 mL)和全剂量 PD(f-PD)组(透析剂量≥8000 mL)。比较两组患者的人口统计学、临床指标、腹膜转运功能、透析充分性和腹膜透析并发症。

结果

(1)i-PD 组 111 例(平均年龄 45.01±12.84 岁),f-PD 组 58 例(平均年龄 43.5±15.62 岁)。PD 前两组患者的人口统计学和临床指标相似(p<0.05)。(2)随访期间,f-PD 组的透析剂量超过 i-PD 组(p<0.05)。两组的透析充分性均符合预期。(3)随访期间,两组腹膜转运功能、RRF、血压控制、贫血纠正和钙磷异常纠正情况相似。(4)两组腹膜透析相关感染、机械并发症和技术生存率相似。

结论

IPD 不会导致 USPD 患者 RRF 快速下降。其透析效果和并发症与全剂量腹膜透析相似。因此,USPD 患者可采用 IPD 治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验